ScienceDex / Researcher record
Chavez, Raymond A.
- Xalud Therapeutics, Inc. (no department on record)
From the FY2014 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Early Career
NIH Funding · FY2014
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2011 | $299,331 | 1 | #26,462 |
| 2012 | $996,485 | 1 | #7,043 |
| 2013 | $1,290,905 | 2 | #4,658 |
| 2014 | $950,102 | 3 | #7,318 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20111 record
- FY20121 record
- FY20132 records
- FY2014 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2011 through FY2014Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2014 award records by amount
NIH award records listing Chavez, Raymond A. as a PI. Multi-PI records show the full award amount for context.
- 3U44NS071642-03S1U44Contact PIXT-101: A Novel and Potent Non-Opioid Treatment for Neuropathic Pain$383.7Kaward amount
- 5R43NS081878-02R43Contact PIXT-101: A Potent IL-10 Based Therapy for Treating Multiple Sclerosis.$350Kaward amount
- 5U44NS071642-04U44Contact PIXT-101: A Novel and Potent Non-Opioid Treatment for Neuropathic Pain$216.4Kaward amount
Award organization
Organizations that administered FY2014 awards listing Chavez, Raymond A. as a PI.
FY2014 award administered by Xalud Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2011First NIH AwardXalud Therapeutics, Inc.
- 2012$500K Cumulative Funding
- 2012$1M Cumulative Funding
- 2012Entered Top 50% NationallyRanked #7043
- 2013$2M Cumulative Funding
- 2013Entered Top 25% NationallyRanked #4658